Drug Trial Radar · NCT06455969
Adaptions and Resiliency to Multi-Stressor OpeRations
Last checked: Nov 20, 2026Latest source record: Aug 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
120
Planned (sponsor's estimate)
Start
Jul 15, 2024
Primary completion
Aug 2027
Study completion Aug 2027
Sponsor
- Lead sponsor
- Bradley NindlAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- U.S. Army Medical Research and Development Command
- First posted
- Jun 13, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 40 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Non-combat-related muscle, tendon and bone injuries are the most common injuries suffered by military personnel, particularly in new recruits. These injuries impact military readiness and are responsible for roughly 60% of limited duty days, 65% of soldiers who are unable to deploy, and nearly $500 million in medical cost to the government annually in the Army alone. Drug interventions must be studied and developed to prevent these negative outcomes and prepare military personnel for the demands of military service. At the current time, military leadership has identified critical gaps in understanding how to minimize these injuries and train soldiers with drug intervention serving among those gaps. The goal of this study is to determine how a hormonal intervention can change muscle, tendon, and bone function as well as physical and psychological performance in response to mental and physical stress. To do so, we will examine sex hormone (testosterone, estrogen) levels, muscle, tendon, and bone images, blood samples, and physical and mental performance. We will look at things like changes in hormone levels, chemicals released from active skeletal muscles, and your body composition. The results from this study will be used to improve physical readiness training in the military with the goal of reducing injuries.
Conditions
- Musculoskeletal Injury
- Hypogonadism
- Hormonal Contraception
Interventions
Goserelin 3.6 MGDrug
Goserelin acetate (Zoladex) is a gonadotropin-releasing hormone agonist (GnRH). GnRH agonists induce a transient increase in sex hormone concentrations, but subsequently inhibit gonadotropin secretion and the production of testosterone in men and estrogen in women. An equilibration period will occur to allow steroid concentrations to reduce.
Multi-Stressor TrainingOther
A 4-week physical training program that mimics military training.
Testosterone gel (AndroGel 5g)Drug
Male subjects will be randomly assigned to receive a topical testosterone gel (5g dose).
Testosterone gel (AndroGel 1.25g)Drug
Male subjects will be randomly assigned to receive a topical testosterone gel (1.25g dose).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Biomechanical: Tendon Cross-Sectional Area, change from baseline and throughout training, meanTime frame: Through study completion, an average of 8 weeks
- Biomechanical: Tendon Shear Wave Elastography, change from baseline and throughout training, meanTime frame: Through study completion, an average of 8 weeks
- Biomechanical: Tendon Thickness, change from baseline and throughout training, meanTime frame: Through study completion, an average of 8 weeks
- Biomechanical: Quadriceps Muscle Cross-sectional Area, change from baseline and throughout training, meanTime frame: Through study completion, an average of 8 weeks
- Biomechanical: Quadriceps Muscle Echointensity, change from baseline and throughout training, meanTime frame: Through study completion, an average of 8 weeks
- Body composition: Lean mass, change from baseline, meanTime frame: Through study completion, an average of 8 weeks
- Body Composition: Fat mass, change from baseline, meanTime frame: Through study completion, an average of 8 weeks
- Body Composition: Body mass, change from baseline and throughout training, meanTime frame: Through study completion, an average of 8 weeks
- Body Composition: Body Fat Percentage, change from baseline, meanTime frame: Through study completion, an average of 8 weeks
- Biochemical: Bone turnover markers (CTx + P1NP), change from baseline, meanTime frame: Through study completion, an average of 8 weeks
- Biochemical: Sex steroid hormones (Testosterone, Sex Hormone Binding Globulin, Estradiol), change from baseline and throughout training, meanTime frame: Through study completion, an average of 8 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Neuromuscular Research Laboratory
Pittsburgh, Pennsylvania · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.